Murata Y, Magner J A, Refetoff S
Endocrinology. 1986 Apr;118(4):1614-21. doi: 10.1210/endo-118-4-1614.
T4-binding globulin (TBG), the principal carrier of thyroid hormone in serum, is a glycoprotein containing 20% carbohydrate. The importance of the carbohydrate moiety has been previously studied by enzymatic deglycosylation, which showed that deglycosylated TBG retains its original immunological an T4-binding properties. However, the structure and properties of TBG before glycosylation and the steps involved in carbohydrate addition have not been explored. In the present report, we used a human hepatoma cell line (Hep G2) which synthesizes and secretes TBG into the medium. This TBG binds T4 and possesses immunoreactivity and microheterogeneity identical to those of native TBG (nTBG) from serum. Cells were pulsed with [35S]methionine, [3H]mannose, and [3H]glucosamine in the absence or presence of 5 micrograms tunicamycin/ml medium. Materials from cells and media were immunoprecipitated with antibodies specific for nTBG and denatured TBG molecule. They were then analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Cells incubated with [35S]methionine contained two forms of labeled TBG, with apparent mol wt of 60K (TBG1) and 54K (TBG2). Medium contained only the TBG1 form, which is identical to nTBG in serum. In contrast, in the presence of tunicamycin, the predominant intracellular form of TBG had an apparent mol wt of 44K (TBG3). At no time was this material detected in the medium. [3H]Mannose and [3H]glucosamine labeled both TBG1 and TBG2, but not TBG3. TBG1 and TBG2 reacted with anti-nTBG serum, whereas TBG3 reacted only with anti-dentured TBG serum, specific for the unfolded TBG molecule. Intracellular TBG was rich (80-90%) in high mannose (seven to nine mannose residues) oligosaccharides and was relatively poor (10-20%) in complex-type species, resistant to endoglycosidase H. These results indicate that 1) the precursor nonglycosylated 44K TBG3 is glycosylated to produce TBG2 (54K) and TBG1 (60K); 2) TBG2 contains oligosaccharides rich in mannose and appears to be a major intracellular intermediate in the synthesis of TBG1; 3) only the endoglycosidase H-resistant TBG1 is secreted; and 4) prior glycosylation of TBG appears to be required for the molecule to assume its tertiary structure and, ultimately, for its secretion. However, once the peptide chain is folded, removal of the carbohydrate moieties does not alter the tertiary structure.
甲状腺素结合球蛋白(TBG)是血清中甲状腺激素的主要载体,是一种含糖量为20%的糖蛋白。先前已通过酶促去糖基化研究了碳水化合物部分的重要性,结果表明去糖基化的TBG保留了其原始的免疫和T4结合特性。然而,糖基化前TBG的结构和特性以及碳水化合物添加所涉及的步骤尚未得到探索。在本报告中,我们使用了一种人肝癌细胞系(Hep G2),该细胞系合成并将TBG分泌到培养基中。这种TBG结合T4,并具有与血清中天然TBG(nTBG)相同的免疫反应性和微不均一性。在不存在或存在5微克/毫升衣霉素的培养基中,用[35S]甲硫氨酸、[3H]甘露糖和[3H]葡糖胺对细胞进行脉冲标记。用针对nTBG和变性TBG分子的特异性抗体对细胞和培养基中的物质进行免疫沉淀。然后通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳进行分析。用[35S]甲硫氨酸孵育的细胞含有两种形式的标记TBG,表观分子量分别为60K(TBG1)和54K(TBG2)。培养基中仅含有TBG1形式,它与血清中的nTBG相同。相反,在衣霉素存在的情况下,TBG的主要细胞内形式的表观分子量为44K(TBG3)。在培养基中未检测到这种物质。[3H]甘露糖和[3H]葡糖胺标记了TBG1和TBG2,但未标记TBG3。TBG1和TBG2与抗nTBG血清反应,而TBG3仅与针对未折叠TBG分子的抗变性TBG血清反应。细胞内的TBG富含(80 - 90%)高甘露糖(七至九个甘露糖残基)寡糖,而对内切糖苷酶H有抗性的复合型寡糖相对较少(10 - 20%)。这些结果表明:1)前体非糖基化的44K TBG3被糖基化以产生TBG2(54K)和TBG1(60K);2)TBG2含有富含甘露糖的寡糖,似乎是TBG1合成中的主要细胞内中间体;3)只有对内切糖苷酶H有抗性的TBG1被分泌;4)TBG的预先糖基化似乎是该分子形成其三级结构以及最终分泌所必需的。然而,一旦肽链折叠,碳水化合物部分的去除不会改变三级结构。